PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"34347950","Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19","O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team.","N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.","O'Brien MP","N Engl J Med","2021","2021/08/04","PMC8362593","","10.1056/NEJMoa2109682"
"35138909","Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency","Lahman MC, Schmitt TM, Paulson KG, Vigneron N, Buenrostro D, Wagener FD, Voillet V, Martin L, Gottardo R, Bielas J, McElrath JM, Stirewalt DL, Pogosova-Agadjanyan EL, Yeung CC, Pierce RH, Egan DN, Bar M, Hendrie PC, Kinsella S, Vakil A, Butler J, Chaffee M, Linton J, McAfee MS, Hunter DS, Bleakley M, Rongvaux A, Van den Eynde BJ, Chapuis AG, Greenberg PD.","Sci Transl Med. 2022 Feb 9;14(631):eabg8070. doi: 10.1126/scitranslmed.abg8070. Epub 2022 Feb 9.","Lahman MC","Sci Transl Med","2022","2022/02/09","PMC8985599","NIHMS1784706","10.1126/scitranslmed.abg8070"
"36316476","Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","Fourati S, Tomalin LE, Mulè MP, Chawla DG, Gerritsen B, Rychkov D, Henrich E, Miller HER, Hagan T, Diray-Arce J, Dunn P; Human Immunology Project Consortium (HIPC); Levy O, Gottardo R, Sarwal MM, Tsang JS, Suárez-Fariñas M, Pulendran B, Kleinstein SH, Sékaly RP.","Nat Immunol. 2022 Dec;23(12):1777-1787. doi: 10.1038/s41590-022-01329-5. Epub 2022 Oct 31.","Fourati S","Nat Immunol","2022","2022/11/01","PMC9747610","","10.1038/s41590-022-01329-5"
"35029629","Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial","O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team.","JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939.","O'Brien MP","JAMA","2022","2022/01/14","PMC8808333","","10.1001/jama.2021.24939"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"26827165","Selection of HIV vaccine candidates for concurrent testing in an efficacy trial","Huang Y, DiazGranados C, Janes H, Huang Y, deCamp AC, Metch B, Grant S, Sanchez B, Phogat S, Koutsoukos M, Kanesa-Thasan N, Bourguignon P, Collard A, Buchbinder S, Tomaras GD, McElrath J, Gray G, Kublin JG, Corey L, Gilbert PB.","Curr Opin Virol. 2016 Apr;17:57-65. doi: 10.1016/j.coviro.2016.01.007. Epub 2016 Jan 29.","Huang Y","Curr Opin Virol","2016","2016/02/01","PMC4902743","NIHMS756136","10.1016/j.coviro.2016.01.007"
"37289667","Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants","Espy N, Han X, Grant S, Kwara E, Lakshminarayanan B, Stirewalt M, Seaton KE, Tomaras GD, Goecker E, McElrath J, Andriesen J, Huang Y, Walsh SR, Hural J.","PLOS Glob Public Health. 2023 Jun 8;3(6):e0002037. doi: 10.1371/journal.pgph.0002037. eCollection 2023.","Espy N","PLOS Glob Public Health","2023","2023/06/08","PMC10249892","","10.1371/journal.pgph.0002037"
"34843602","Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials","Fischinger S, Cizmeci D, Deng D, Grant SP, Frahm N, McElrath J, Fuchs J, Bart PA, Pantaleo G, Keefer M, O Hahn W, Rouphael N, Churchyard G, Moodie Z, Donastorg Y, Streeck H, Alter G.","PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov.","Fischinger S","PLoS Pathog","2021","2021/11/29","PMC8659322","","10.1371/journal.ppat.1010016"
"35353885","High Asymptomatic Carriage With the Omicron Variant in South Africa","Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, Espy N, Wallis CL, Randhawa AK, Miner MD, Ketter N, Yacovone M, Goga A, Huang Y, Hural J, Kotze P, Bekker LG, Gray GE, Corey L; Ubuntu Study Team.","Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.","Garrett N","Clin Infect Dis","2022","2022/03/30","PMC9383623","","10.1093/cid/ciac237"
"34452338","Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency","Gornalusse GG, Vojtech LN, Levy CN, Hughes SM, Kim Y, Valdez R, Pandey U, Ochsenbauer C, Astronomo R, McElrath J, Hladik F.","Viruses. 2021 Jul 27;13(8):1472. doi: 10.3390/v13081472.","Gornalusse GG","Viruses","2021","2021/08/28","PMC8402857","","10.3390/v13081472"
"25908275","Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data","Lin L, Frelinger J, Jiang W, Finak G, Seshadri C, Bart PA, Pantaleo G, McElrath J, DeRosa S, Gottardo R.","Cytometry A. 2015 Jul;87(7):675-82. doi: 10.1002/cyto.a.22623. Epub 2015 Apr 23.","Lin L","Cytometry A","2015","2015/04/25","PMC4482785","NIHMS673317","10.1002/cyto.a.22623"
"36266291","The Immune Signatures data resource, a compendium of systems vaccinology datasets","Diray-Arce J, Miller HER, Henrich E, Gerritsen B, Mulè MP, Fourati S, Gygi J, Hagan T, Tomalin L, Rychkov D, Kazmin D, Chawla DG, Meng H, Dunn P, Campbell J; Human Immunology Project Consortium (HIPC); Sarwal M, Tsang JS, Levy O, Pulendran B, Sekaly R, Floratos A, Gottardo R, Kleinstein SH, Suárez-Fariñas M.","Sci Data. 2022 Oct 20;9(1):635. doi: 10.1038/s41597-022-01714-7.","Diray-Arce J","Sci Data","2022","2022/10/20","PMC9584267","","10.1038/s41597-022-01714-7"
"28131393","Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials","Huang Y, Zhang L, Janes H, Frahm N, Isaacs A, Kim JH, Montefiori D, McElrath MJ, Tomaras GD, Gilbert PB.","Vaccine. 2017 Feb 22;35(8):1184-1193. doi: 10.1016/j.vaccine.2016.09.053. Epub 2017 Jan 25.","Huang Y","Vaccine","2017","2017/01/30","PMC5319823","NIHMS842454","10.1016/j.vaccine.2016.09.053"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"22851315","HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly","Reed JC, Molter B, Geary CD, McNevin J, McElrath J, Giri S, Klein KC, Lingappa JR.","J Cell Biol. 2012 Aug 6;198(3):439-56. doi: 10.1083/jcb.201111012. Epub 2012 Jul 30.","Reed JC","J Cell Biol","2012","2012/08/02","PMC3413349","","10.1083/jcb.201111012"
"28687661","A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine","Hou J, Wang S, Jia M, Li D, Liu Y, Li Z, Zhu H, Xu H, Sun M, Lu L, Zhou Z, Peng H, Zhang Q, Fu S, Liang G, Yao L, Yu X, Carpp LN, Huang Y, McElrath J, Self S, Shao Y.","J Immunol. 2017 Aug 15;199(4):1476-1489. doi: 10.4049/jimmunol.1700083. Epub 2017 Jul 7.","Hou J","J Immunol","2017","2017/07/09","PMC6681914","NIHMS1039363","10.4049/jimmunol.1700083"
"36689221","Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials","Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG; COVID-19 Prevention Network.","JAMA Netw Open. 2023 Jan 3;6(1):e2251974. doi: 10.1001/jamanetworkopen.2022.51974.","Mena Lora AJ","JAMA Netw Open","2023","2023/01/23","","","10.1001/jamanetworkopen.2022.51974"
"24560541","Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study","Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.","Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.","Gray GE","Lancet Infect Dis","2014","2014/02/25","PMC4174314","NIHMS588579","10.1016/S1473-3099(14)70020-9"
"21570355","Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.","Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11.","Gray GE","Lancet Infect Dis","2011","2011/05/17","PMC3417349","NIHMS357717","10.1016/S1473-3099(11)70098-6"
"16847956","Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection","Yu J, Chen H, Horton H, Bansal A, McElrath JM, Reichman R, Goepfert P, Jin X.","J Med Virol. 2006 Sep;78(9):1147-57. doi: 10.1002/jmv.20675.","Yu J","J Med Virol","2006","2006/07/19","","","10.1002/jmv.20675"
"18384232","Improving defences at the portal of HIV entry: mucosal and innate immunity","Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J; Working Group convened by the Global HIV Vaccine Enterprise.","PLoS Med. 2008 Apr 1;5(4):e81. doi: 10.1371/journal.pmed.0050081.","Shattock RJ","PLoS Med","2008","2008/04/04","PMC2276525","","10.1371/journal.pmed.0050081"
"23370155","Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?","Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, Moodie Z, Kublin J, Bekker LG; HVTN 503 team.","Vaccine. 2013 Apr 12;31(16):2089-96. doi: 10.1016/j.vaccine.2013.01.031. Epub 2013 Jan 29.","Gray GE","Vaccine","2013","2013/02/02","PMC3942784","NIHMS487911","10.1016/j.vaccine.2013.01.031"
"23349878","Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review","Elizaga ML, Vasan S, Marovich MA, Sato AH, Lawrence DN, Chaitman BR, Frey SE, Keefer MC; MVA Cardiac Safety Working Group.","PLoS One. 2013;8(1):e54407. doi: 10.1371/journal.pone.0054407. Epub 2013 Jan 17.","Elizaga ML","PLoS One","2013","2013/01/26","PMC3547923","","10.1371/journal.pone.0054407"
"22561365","Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)","Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team.","J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4.","Duerr A","J Infect Dis","2012","2012/05/08","PMC3490694","","10.1093/infdis/jis342"
